Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
P3 Health PartnersPIIIW +41.54%51 EBITDA Margin % is 11.86% as of Jun. 2026. GuruFocus rates PIIIW with a GF Score™ of 51/100. The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, P3 Health Partners ranks worse than 79.34% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. P3 Health Partners's EBITDA for the
three
months ended in Jun. 2026 was $45.82 Mil. P3 Health Partners's Revenue for the
three
months ended in Jun. 2026 was $386.38 Mil. Therefore, P3 Health Partners's EBITDA margin for the quarter that ended in Jun. 2026 was 11.86%.
P3 Health Partners (NAS:PIIIW) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
P3 Health Partners EBITDA Margin % Related Terms
P3 Health Partners EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for P3 Health Partners's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PIIIW vs DCGO, CCEL, BTMD: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, P3 Health Partners's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
P3 Health Partners EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners (PIIIW) has a EBITDA Margin % of 11.86% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #530 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 79.3%.
Is P3 Health Partners' EBITDA Margin % too high?
P3 Health Partners' current EBITDA Margin % is 11.86%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.18. P3 Health Partners' value of 11.86% is 16.5% above this industry median. Based on the distribution chart, P3 Health Partners ranks #530 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, P3 Health Partners has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' EBITDA Margin % compare to DCGO and CCEL?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #530 out of 668 companies for EBITDA Margin %. This places P3 Health Partners in the lower half of its industry. The industry median EBITDA Margin % is 10.18. P3 Health Partners' value of 11.86% is 16.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.18, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. P3 Health Partners's current EBITDA Margin % of 11.86% is 16.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on P3 Health Partners and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. P3 Health Partners's current EBITDA Margin % is 11.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
P3 Health Partners (PIIIW) has a current EBITDA Margin % of 11.86%. The current EBITDA Margin % is 11.86% and 16.5% above the Healthcare Providers & Services industry median of 10.18. P3 Health Partners' overall GF Score™ is 51/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For P3 Health Partners (PIIIW), the current EBITDA Margin % is 11.86% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
51GF Score
Get the complete analysis for PIIIW
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIIIW has been successfully added to your 
